One year outcomes and costs following a vertebral fracture

Osteoporosis International

Volumn 16, Issue 1, 2005, Pages 78-85

  Lindsay, R ^a   Burge, R T ^b,c   Strauss, D M ^b  

^a HELEN HAYES HOSPITAL   (United States)

^b PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

^c BOSTON UNIVERSITY   (United States)

Author keywords

Costs; Osteoporosis; Outcomes; Refracture; Vertebral fractures

Indexed keywords

RISEDRONIC ACID;

ARTICLE; FOREARM FRACTURE; HEALTH CARE COST; HIP FRACTURE; INCIDENTAL FINDING; KAPLAN MEIER METHOD; PRIORITY JOURNAL; SWEDEN; TREATMENT OUTCOME; VERTEBRA FRACTURE; WRIST FRACTURE;

AGED; CLINICAL TRIALS, PHASE III; COSTS AND COST ANALYSIS; DECISION TREES; FEMALE; FOREARM INJURIES; HIP FRACTURES; HUMANS; OSTEOPOROSIS; OUTCOME ASSESSMENT (HEALTH CARE); PROBABILITY; RECURRENCE; SPINAL FRACTURES; WRIST INJURIES;

EID: 13244265625     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00198-004-1646-x     Document Type: Article

References (35)

1. Ross PD, Davis JW, Epstein RS, Wasnich RD (1991) Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Int Med 114:919-923
2. Ross PD, Genant HK, Davis JW, Miller PD, Wasnich RD (1993) Predicting vertebral fracture incidence from prevalent fractures and bone mass density among non-black, osteoporotic women. Osteoporos Int 3:120-126
3. Black DM, Arden NK, Palermo L, Pearson M, Cummings SR (1999) Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. J Bone Miner Res 14:821-828
4. Kotowicz M, Melton LJ, Cooper C, Atkinson EJ, O'Fallon WM, Riggs BL (1994) Risk of hip fracture in women with vertebral fracture. J Bone Miner Res 5:599-605
5. Johnell O, Kanis JA, Oden A, Sernbo I et al. (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15:175-179.
6. Melton LJ, Atkinson EJ, Cooper C, O'Fallon W, Riggs BL (1999) Vertebral fractures predict subsequent fractures. Osteoporos Int 10:214-221
7. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721-739
8. van Staa TP, Leufkens HG, Cooper C (2002) Does a fracture at one site predict later fractures at other sites? A British cohort study. Osteoporos Int 13:624-629
9. Cooper C, Atkinson EJ, O'Fallon W, Melton LJ (1992) Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota: 1985-1989. J Bone Miner Res 7:221-227
10. Clark AP, Schuttinga JA (1992) Targeted estrogen/progestogen replacement therapy for osteoporosis: calculation of health care cost savings. Osteoporos Int 2:195-200
11. Gehlbach SH, Bigelow C, Heimisdottir M, May S, Walker M, Kirkwood JR (2000) Recognition of vertebral fracture in a clinical setting. Osteoporos Int 11:577-582
12. Burge RT, Puleo E, Gehlbach S, Worley D, Klar J (2002) Inpatient hospital and post-acute care for vertebral fractures in women. Value-In-Health 5:301-311
13. Gehlbach SH, Burge RT, Puleo E, Klar J (2003) Hospital care of osteoporosis-related vertebral fractures. Osteoporos Int 14:53-60
14. Ray NF, Chan JK, Thamer M, Melton LJ (1997) Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 12:24-35
15. Phillips S, Fox N, Jacobs J, Wright W (1988) The Direct medical costs of osteoporosis for American women aged 45 and older, 1986. Bone 9:271-279
16. Chrischilles E, Shireman T, Wallace R (1994) Costs and health effects of osteoporotic fractures. Bone 15:377-386
17. US Congress Office of Technical Assistance (1994) Hip fracture outcomes in people age fifty and over: background paper. US Government Printing Office, Washington, D.C.
18. Decision Analysis by TreeAge (DATA), Version 3.5.4. TreeAge Software, Inc. Williamstown, Mass., USA
19. Harris ST, Watts NB, Genant HK et al. (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. JAMA 280:2077-2082
20. Reginster J, Minne HW, Sorensen OH et al. (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 11:83-91
21. McClung MR, Geusens P, Miller PD et al. (2001) Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 344:333-340
22. Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, Licata A, Benhamou L, Geusens P, Flowers K, Stracke H, Seeman E (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285:320-323
23. National Osteoporosis Foundation (1998) Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effective analysis. Osteoporos Int Supplement 4:s1-s88
24. Nationwide Inpatient Sample, Release 6 (1997) Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality, Rockville, Maryland, USA
25. Hoerger T, Downs K, Lakshmanan M et al. (1999) Healthcare use among US women aged 45 and older: total costs and costs for selected postmenopausal health risks. J Women's Health Gender-Based Med 8:1077-1089
26. Jacobsen SJ, Cooper C, Gottlieb MS et al. (1992) Hospitalization with vertebral fracture among the aged: a national population-based study, 1986-1989. Epidemiology 3:515-518
27. Ankjaer-Jensen A, Johnell O (1996) Prevention of osteoporosis: cost-effectiveness of different pharmaceutical treatments. Osteoporos Int 6:265-275
28. Cooper C, O'Neill T, Silman AJ (1993) European Vertebral Osteoporosis Study Group. The epidemiology of vertebral fractures. Bone 14:889-97
29. Holbrook TL et al. (1984) The frequency of occurrence, impact, and cost of selected musculoskeletal conditions in the US. American Academy of Orthopedic Surgeons, Chicago
30. Zethraeus N, Strömberg L, Jönsson B, Svensson O, Öhlén G (1997) The cost of a hip fracture. Estimates for 1709 patients in Sweden. Acta Orthop Scand 68:13-17
31. Zethraeus N, Borgström F, Johnell O, Kanis J, Önnby K, Jönsson B (2002) Costs and quality of life associated with osteoporosis related fractures - results from a Swedish survey. SSE/EFI Working Paper Series in Economics and Finance, No 512, October
32. Gabriel SE, Tosteson ANA, Leibson CL et al. (2002) Direct medical costs attributable to osteoporotic fractures. Osteoporos Int 13:323-330
33. De Laet C, van Hout BA, Burger H et al. (1999) Incremental cost of medical care after hip fracture and first vertebral fracture: the Rotterdam study. Osteoporos Int 10:66-72
34. Tosteson ANA, Gabriel SE, Grove MR et al. (2001) Impact of hip and vertebral fractures on quality-adjusted life years. Osteoporos Int 12:1042-1049
35. Kanis JA, Johnell O, Oden A, Borgstrom F, Zethraeus N, De Laet C, Jonsson B (2004) The risk of vertebral fractures in Sweden. Osteoporos Int 15:20-26